2024-03-28 17:13:08 ET
Inhibikase Therapeutics, Inc. (IKT)
Q4 2023 Earnings Call Transcript
March 28, 2024 08:00 AM ET
Company Participants
Alex Lobo - Stern Investor Relations
Milton Werner - CEO
Garth Lees-Rolfe - CFO
Conference Call Participants
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Greetings, and welcome to Inhibikase Therapeutics Fourth Quarter and Full Year 2023 Financial Results. At this time, all participants will be in listen-only mode. A question-and-answer session will follow the formal presentation. Please note that today's conference is being recorded. [Operator Instructions]
I'll now turn the call over to Alex Lobo, Stern Investor Relations. Alex, you may now begin....
Read the full article on Seeking Alpha
For further details see:
Inhibikase Therapeutics, Inc. (IKT) Q4 2023 Earnings Call Transcript